Erasca to be valued at up to $1.8 billion after terms of IPO were set
Marketwatch -

Erasca Inc. disclosed Monday that it has set terms of its initial public offering, in which the California-based pre-revenue, clinical-stage precision oncology company could be valued up to $1.84 billion. The company is looking to raise up to $280.0 million in the IPO, as it is offering 17.5 million shares and the IPO is expected to price between $14 and $16 a share. The company is expected to have 114.9 million shares outstanding after the IPO. The stock is expected to list on the Nasdaq...

Read this story at

Loading...

Related Articles